SureTrader
Home > Boards > US OTC > Biotechs > PharmaCyte Biotech Inc. (PMCB)

NVLX

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NYC Trader Member Profile
 
Followed By 1,068
Posts 143,448
Boards Moderated 5
Alias Born 01/25/09
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 12/14/2017 4:51:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/10/2017 8:31:01 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/29/2017 6:01:57 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/28/2017 4:18:18 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/13/2017 9:26:54 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 9/13/2017 6:06:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/6/2017 8:00:54 AM
Annual Report (10-k) Edgar (US Regulatory) - 7/27/2017 5:24:39 PM
PharmaCyte Biotech Appoints Dr. Linda S. Sher as Chief Medical Officer GlobeNewswire Inc. - 7/26/2017 9:00:00 AM
PharmaCyte Biotech Appoints Dr. Michael M. Abecassis to Board of Directors GlobeNewswire Inc. - 7/10/2017 9:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/10/2017 6:04:49 AM
PharmaCyte Biotech Releases Presentation to Oncologists and Interviews from 2017 ASCO Meeting Event GlobeNewswire Inc. - 7/6/2017 9:00:00 AM
PharmaCyte Biotech to Present Pancreatic Cancer Therapy at 2017 BIO International Convention GlobeNewswire Inc. - 6/13/2017 9:20:00 AM
PharmaCyte Biotech Updates Shareholders on ASCO Presentation to Oncologists GlobeNewswire Inc. - 6/9/2017 9:20:00 AM
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology GlobeNewswire Inc. - 5/31/2017 9:20:00 AM
PharmaCyte Biotech Updates IND Submission Process in Interview with Facet Life Sciences GlobeNewswire Inc. - 5/8/2017 9:00:00 AM
PharmaCyte Biotech Appoints Thomas Yuen to Board of Directors GlobeNewswire Inc. - 5/2/2017 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/2/2017 8:08:49 AM
PharmaCyte Biotech Receives the 2017 “Pipelines of Promise” Award from BIO International GlobeNewswire Inc. - 4/19/2017 9:20:00 AM
PharmaCyte Biotech Discusses Future of Cannabis Research Program, Competitors and More with Program’s Director GlobeNewswire Inc. - 4/18/2017 9:00:00 AM
PharmaCyte Biotech’s Cannabis Research Program Sees Significant Progress in University of Northern Colorado Presentations GlobeNewswire Inc. - 4/10/2017 9:00:00 AM
PharmaCyte Biotech Appoints Dr. Mark Rabe Director of Cannabis Program Development GlobeNewswire Inc. - 4/3/2017 9:20:00 AM
PharmaCyte Biotech Strengthens Protection of Cancer Therapy with Patent Filing GlobeNewswire Inc. - 3/22/2017 9:20:00 AM
PharmaCyte Biotech CEO Addresses IND Submission Questions GlobeNewswire Inc. - 3/17/2017 9:00:00 AM
PharmaCyte Biotech Names Dr. Leonard Makowka as Senior Strategic Advisor GlobeNewswire Inc. - 3/13/2017 9:00:00 AM
NYC Trader   Friday, 05/10/13 07:49:08 AM
Re: None
Post # of 80854 
NVLX
Link: http://www.otcmarkets.com/stock/NVLX/company-info
Ticker: $NVLX
OTC Market Tier: OTCQB
CIK code: 0001157075
Company name: Nuvilex, Inc.
Company website: http://www.nuvilex.com
Incorporated In: NV, USA



Visit my board"NY Penny Stock Exchange" for today's pick at http://investorshub.advfn.com/boards/board.aspx?board_id=16752
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist